Nasal COVID-19 Vaccine Secures Federal Funding for Groundbreaking Clinical Trial
CyanVac LLC is set to begin a federally funded Phase 2b trial this fall for its intranasal COVID-19 vaccine, CVXGA,…
Bringing News as it Unfolds
CyanVac LLC is set to begin a federally funded Phase 2b trial this fall for its intranasal COVID-19 vaccine, CVXGA,…